𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?

✍ Scribed by Shurin, Michael R; Gregory, Melissa; Morris, John C; Malyguine, Anatoli M

Book ID
111985701
Publisher
Informa plc
Year
2010
Tongue
English
Weight
469 KB
Volume
10
Category
Article
ISSN
5847-4714

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genetic approaches for the induction of
Genetic approaches for the induction of a CD4+ T cell response in cancer immunotherapy
✍ Aude Bonehill; Carlo Heirman; Kris Thielemans 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB

## Abstract Recently, it has become more and more obvious that not only CD8^+^ cytotoxic T lymphocytes, but also CD4^+^ T helper cells are required for the induction of an optimal, long‐lasting anti‐tumor immune response. CD4^+^ T helper cells, and in particular IFN‐γ‐secreting type 1 T helper cell

Stimulatory effects of CpG oligodeoxynuc
Stimulatory effects of CpG oligodeoxynucleotide on dendritic cell-based immunotherapy of colon cancer in CEA/HLA-A2 transgenic mice
✍ Asim Saha; Malaya Bhattacharya-Chatterjee; Kenneth A. Foon; Esteban Celis; Sunil 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 250 KB

## Abstract Immunostimulatory DNA containing unmethylated cytosine‐guanine (CpG) motifs have been successfully used as adjuvants to enhance the immunity of vaccines designed to trigger antitumor T‐cell responses. We examined the effect of a CpG oligodeoxynucleotide (CpG ODN) for its ability to pote

Successful cancer vaccine therapy for ca
Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)-expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice
✍ Toshiyasu Ojima; Makoto Iwahashi; Masaki Nakamura; Kenji Matsuda; Mikihito Nakam 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 755 KB

## Abstract This study was designed to determine whether the vaccination of genetically modified dendritic cells (DCs) simultaneously expressing carcinoembryonic antigen (CEA), granulocyte macrophage colony‐stimulating factor (GM‐CSF) and interleukin 12 (IL‐12) can overcome the peripheral T‐cell to

Interleukin-17 as a molecular target in
Interleukin-17 as a molecular target in immune-mediated arthritis: Immunoregulatory properties of genetically modified murine dendritic cells that secrete interleukin-4
✍ Sujata Sarkar; Laura A. Tesmer; Vindhya Hindnavis; Judith L. Endres; David A. Fo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB

## Abstract ## Objective Our previous studies have shown that murine dendritic cells (DCs) genetically modified to express interleukin‐4 (IL‐4) reduce the incidence and severity of murine collagen‐induced arthritis. The present studies were performed to assess the immunoregulatory mechanisms under